---
format:
   revealjs:
     css: style.css
     incremental: true
     slide-number: true
     footer: "&copy; 2025 Eli Lilly and Company"
     view-distance: 100
     mobile-view-distance: 100
---

##

```{r, include = FALSE, echo = FALSE}
set.seed(0)
suppressPackageStartupMessages({
  library(targets)
})
knitr::opts_chunk$set(
  cache = FALSE,
  comment = "#>",
  echo = TRUE,
  eval = FALSE,
  fig.width = 10, 
  fig.height = 5
)
```

<style>
.reveal .tiny {
  display: inline-block;
  font-size: 0.5em;
  line-height: 1.0em;
  vertical-align: top;
}
.reveal .medium {
  display: inline-block;
  font-size: 0.75em;
  line-height: 1.5em;
  vertical-align: top;
}
</style>

<center>
<br>
<h3>Powerful simulation pipelines with {targets}</h3>
<img src="./images/targets.png" height="400px">
<br>
<h4>Will Landau</h4>
</center>

## Background

* Training
    * Iowa State University 2011-2016.
    * Bayesian Statistics.
* Career
    * Eli Lilly and Company, 2016-present.
    * Methods and tools for clinical trials.
    * Author of the `targets` package.

## Agenda

<br>

<center>
<img src="./images/agenda.png">
</center>

# Clinical trial simulation

## Drug development

<center>
<img src="./images/process.png">
</center>


## Clinical trials

<center>
<img src="./images/clinical.png">
</center>

## Responsibilities

<center>
<img src="./images/responsibility.png">
</center>

## Clinical trial simulation: goals

<center>
<img src="./images/goals.jpg" height="300px">
</center>

. . .

Quantify decision-making ability.

. . .

Compare alternative designs.

## Clinical trial simulation: steps

<center>
<img src="./images/steps.jpg" height="300px">
</center>

1. Simulate virtual patients.
1. Analyze with models.
1. Repeat thousands of times.

## Clinical trial simulation: challenges

<center>
<img src="./images/challenges.jpg" height="300px">
</center>

. . .

Complicated R code.

. . .

Long execution times.

. . .

Frequent changes.

# Example trial

## Hypothetical trial

<center>
<img src="./images/stethoscope.jpg" height="300px">
</center>

. . .

Extremely rare autoimmune liver disease.

. . .

Phase 2 study, first look at efficacy.

. . .

Novel therapy vs active control.

. . .

Randomize up to 100 patients (1:1).

## Bayesian joint model {.nonincremental}

:::{.fragment}

#### Longitudinal endpoint: log bilirubin

$$
\begin{aligned}
\color{orange}{\eta_i(t)} = x_i(t) \beta + b_i
\end{aligned}
$$

:::

. . .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $\color{orange}{\eta_i(t)}$: expected log bilirubin for patient $i$ at time $t$. 

:::{.fragment}

#### Survival endpoint: years without liver transplant or death

$$
\begin{aligned}
h_i(t) = h_0(t, \lambda) \exp \left (\color{orange}{\eta_i(t)} \alpha + d_i \color{blue}{\theta} \right )
\end{aligned}
$$

:::

. . .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $d_i$: 1 for treatment, 0 for control.

. . .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $\color{blue}{\theta}$: log hazard ratio of treatment vs control.

## Decision rules {.nonincremental}


$$
\begin{aligned}
g(y) = \text{P}(\exp(\color{blue}{\theta}) < 0.75 \ | \ y)
\end{aligned}
$$

:::{.fragment}

#### Declare efficacy if:

$$
\begin{aligned}
g(y) > 0.8
\end{aligned}
$$
:::

:::{.fragment}

#### Declare futility if:

$$
\begin{aligned}
g(y) < 0.4
\end{aligned}
$$

:::

## Clinical trial design

<center>
<img src="./images/stethoscope.jpg" height="300px">
</center>

. . .

10-year accrual period.

. . .

Futility interim at $n$ events (liver transplant or death).

. . .

**Goal: simulate to propose a suitable $n$**.

## Simulate futility

![](./images/bayes.png)

. . .

Simulate 10000 futile trials for $n = 40, 50, 60, 70$.

. . .

A fixed hazard ratio of 1 would be unrealistic.

. . .

Instead, draw from a distribution that captures futility.

. . .

Use the posterior distribution from a historical trial.

## Historical futility data

<center>
<img src="./images/data.jpg" height="300px">
</center>

. . .

Datasets `pbc` and `pbcseq` from the `survival` package.

. . .

Indication: primary biliary cholangitis (PBC).

. . .

Mayo Clinic trial of D-penicillamine vs placebo.

. . .

D-penicillamine did not improve survival.

## Estimated hazard ratio

<center>
<img src="./images/hazard_ratio.png">
</center>

# R code

## Functions {.nonincremental}

$$
\Huge
{\color{blue}{y}} = {\color{purple}{f}}({\color{teal}{x}})
$$
<br>

> Everything that exists in an object. <br>
> Everything that happens is a function call.
>
> <br>
> — John Chambers

## Top-level R functions

$$
\Huge
{\color{blue}{y}} = {\color{purple}{f}}({\color{teal}{x}})
$$

<br>

Function | Description
---|---
`draw_hazard_ratios()` | From historical model.
`trial()` | Simulate one trial rep.
`plot_results()` | Visualize results.

## Example simulation replication

<center>
<img src="./images/r.png" height="200px">
</center>
<br>

```{r}
trial(hazard_ratio = 0.5, events = 50)
#> # A tibble: 1 × 4
#>   events efficacy enrolled years
#>    <dbl>    <dbl>    <dbl> <dbl>
#> 1     50    0.998       83  8.52
```

## Example simulation replication

<center>
<img src="./images/r.png" height="200px">
</center>
<br>

```{r}
trial(hazard_ratio = 1.2, events = 50)
#> # A tibble: 1 × 4
#>   events efficacy enrolled years
#>    <dbl>    <dbl>    <dbl> <dbl>
#> 1     50   0.0324       72  7.35
```

# Workflow pitfalls

## Scripted simulation 

:::{.nonincremental}

Step 1: draw historical hazard ratios.

```{r}
hazard_ratio <- draw_hazard_ratios(10000)
```

:::{.fragment}

Step 2: run simulations.

```{r}
results <- hazard_ratio |>
  expand_grid(events = c(40, 50, 60, 70)) |>
  pmap(trial) |>
  list_rbind()
```

:::

:::{.fragment}

Step 3: plot results.

```{r}
plot_results(results)
```

:::

:::

## Numbered notebooks?

<center>
<img src="./images/notebook-start.png">
</center>

## What about data?

<center>
<img src="./images/notebook-data.png">
</center>

## Complexity?

<center>
<img src="./images/notebook-change.png">
</center>

## Keeping results up to date?

<center>
<img src="./images/notebook-rerun.png">
</center>

# Pipelines

## What is a pipeline?

<center>
<img src="./images/graph-final.png" height = "300px">
</center>

.  . .

Pipeline: a formal group of tasks.

. . .

Each task declares a command, dependencies, and output.

. . .

A task cannot eventually depend on itself.

## Pipeline tools

<br>

<center>
<img src="./images/infographic.png" height = "300px">
</center>

Examples: Make, Airflow, Nextflow, Prefect, and `targets`.

## targets: a pipeline tool for R

<center>
<img src="./images/logo-tweet.png" height="300px">
</center>

. . .

Retains the comfort of your local R session.

. . .

Declares dependencies implicitly.

. . .

Integrates with Quarto.

. . .

Runs distributed computing.

# Example pipeline

## Project-oriented workflow

<br>

```{r}
fs::dir_tree()
#> _targets.R
#> R
#> ├── draw_hazard_ratios.R
#> ├── plot_results.R
#> ├── trial.R
#> └── utils.R
```

. . .

`R/` scripts contain functions.

. . .

`_targets.R` defines the pipeline.

## Define the pipeline in _targets.R

```{r}
library(targets)

tar_option_set(...)

tar_source()

list(
  tar_target(hazard_ratios, ...),
  tar_target(trials, ...),
  ...
)
```

## Options and parallel computing

```{r}
library(crew.cluster)

controller <- crew_controller_sge(
  workers = 500,
  seconds_idle = 120
)

tar_option_set(
  packages = c("rstanarm", ...),
  controller = controller
)
```

## Inputs

```{r}
tar_target(
  name = hazard_ratios,
  command = draw_hazard_ratios(10000)
)
```

<br>

```{r}
tar_target(
  name = events,
  command = c(40, 50, 60, 70)
)
```

## Simulations

<br>

```{r}
tar_target(
  name = trials,
  command = trial(hazard_ratios, events),
  pattern = cross(hazard_ratios, events)
)
```

## Results

```{r}
tar_target(
  name = plot,
  command = plot_results(trials)
)
```

<br>

```{r}
tarchetypes::tar_quarto(
  name = quarto,
  path = "results.qmd"
)
```

## Quarto report

<center>
<img src="./images/quarto-source.png" height="550px">
</center>

## Connections among targets

```{r}
tar_visnetwork(targets_only = TRUE)
```

<br>

<center>
<img src="./images/graph-outdated.png">
</center>

## Connections to functions

```{r}
tar_visnetwork()
```

<center>
<img src="./images/graph-functions.png">
</center>

# Running the pipeline

## Run the pipeline

```{r}
tar_make(as_job = TRUE)
```

<center>
<img src="./images/workbench.png">
</center>

## Track progress

<br>

```{r}
tar_progress_summary()[, 1:3]
#> # A tibble: 1 × 3
#>   skipped dispatched completed
#>     <int>      <int>     <int>
#> 1       0        500     12613
```

## Track progress

<br>

```{r}
tar_visnetwork(targets_only = TRUE)
```

<center>
<img src="./images/graph-dispatched.png">
</center>

## Simulation results

```{r}
tar_read(trials, branches = seq_len(8))
#> # A tibble: 10 × 4
#>    events efficacy enrolled years
#>     <dbl>    <dbl>    <dbl> <dbl>
#>  1     40   0.055        58  6.31
#>  2     50   0.0685       77  7.99
#>  3     60   0.0602       81  7.93
#>  4     70   0.153        93  9.01
#>  5     40   0.220        65  6.03
#>  6     50   0.479        73  6.43
#>  7     60   0.918        87  8.91
#>  8     70   0.832        89  8.99
```

## Plot

```{r}
tar_read(plot)
```

<center>
<img src="./images/plot.png">
</center>

## Quarto report

::::{.columns}

:::{.column width="50%"}

<center>
<img src="./images/quarto-source.png">
</center>

:::

:::{.column width="50%"}

<center>
<img src="./images/quarto.png">
</center>

:::

::::

## Add a new target

```{r}
tar_target(
  name = years,
  command = plot_years(trials)
)
```

<center>
<img src="./images/graph-years.png">
</center>

## Skip up-to-date targets

<br>

```{r}
tar_make()
#> ...
#> ✔ skipping targets (40002 so far)...
#> ▶ dispatched target years
```

## Years until interim

```{r}
tar_read(years)
```

<center>
<img src="./images/years.png">
</center>

## Change an event threshold

```{r}
tar_target(
  name = events,
  command = c(40, 50, 60, 75)
)
```

<center>
<img src="./images/graph-change-event-threshold.png">
</center>

## Change an upstream function

<center>
<img src="./images/graph-change-function.png">
</center>

## Up-to-date pipeline

```{r}
tar_outdated()
#> character(0)
```

<br>

```{r}
tar_visnetwork(targets_only = TRUE)
```

<center>
<img src="./images/graph-uptodate.png">
</center>

## Conclusions

<center>
<img src="./images/plot-large-font.png" height = "400px">
</center>

. . .

Interim at 40 events looks promising.

. . .

Need to simulate full design with interims and final analysis

# Example pipeline: Bayesian model validation

## Bayesian MMRM

![](./images/fev.png){fig-align="center"}

. . .

MMRM = mixed model for repeated measures.

. . .

Longitudinal data with continuous outcomes.

. . .

Bayesian MMRMs: phase 2 neurology, pulmonology, etc.

## Implementation

![](./images/brms.mmrm.png){fig-align="center"}

## Computational demands of Stan/HMC

![](./images/hmc.png){fig-align="center"}


. . .

HMC = Hamiltonian Monte Carlo.

. . .

Physics simulation samples from the posterior distribution.

## Modeling scenarios

$$
\begin{aligned}
\mathbf{y}_1, \ldots, \mathbf{y}_n \stackrel{\text{ind}}{\sim} \text{MVN}(X_n\mathbf{\beta}, {\color{blue} \Sigma})
\end{aligned}
$$

::: {.nonincremental}

1. Subgroup analysis with unstructured covariance ${\color{blue} \Sigma}$.
2. Unstructured ${\color{blue} \Sigma}$.
3. Autoregressive moving average ${\color{blue} \Sigma}$.
4. Autoregressive ${\color{blue} \Sigma}$.
5. Moving average ${\color{blue} \Sigma}$.
6. Uncorrelated residuals.

:::

## Validation {style="font-size: 90%"}

![](./images/bayes.png){fig-align="center"}

. . . 

Simulation-based calibration (SBC) checking. ([Modrák et al. (2023)](https://projecteuclid.org/journals/bayesian-analysis/volume--1/issue--1/Simulation-Based-Calibration-Checking-for-Bayesian-Computation--The-Choice/10.1214/23-BA1404.full))

. . .

<br>

Problem: easy to simulate from prior, hard to model posterior.

. . .

<br>

Solution: simulation where prior and posterior should agree. 

## Repeat thousands of times: {style="font-size: 85%"}

1. Draw a set of parameters from the prior.

:::{.fragment}

$$
\begin{aligned}
\theta^{\text{sim}} &\sim p(\theta)
\end{aligned}
$$
:::

2. Draw a dataset given parameters from (1).

:::{.fragment}

$$
\begin{aligned}
y^{\text{sim}} &\sim p(y | \theta^{\text{sim}})
\end{aligned}
$$

:::

3. Draw parameter samples from the posterior.

:::{.fragment}

$$
\begin{aligned}
\theta^{(1)}, \ldots, \theta^{(M)} &\sim p(\theta | y^{\text{sim}})
\end{aligned}
$$

:::

## Why SBC works {style="font-size: 80%"}

::: {.nonincremental}

<br>

Equivalent to integrating out $\theta^{\text{sim}}$ and $y^{\text{sim}}$ to get the prior back:

:::

<br>

$$
p(\theta) = \int \int p(\theta | y^{\text{sim}}) p(y^{\text{sim}} | \theta^{\text{sim}}) p(\theta^{\text{sim}}) d \theta^{\text{sim}} d y^{\text{sim}}
$$

<br>

. . .

Use ranks $\sum_{m = 1}^M I \left [ \theta^{(m)}_i < \theta^{\text{sim}}_i
\right ]$ to check that the posterior and prior agree.

. . .

<br>

Ranks should be uniformly distributed.

## Branching with tarchetypes

::: {style="font-size: 0.9em;"}

```r
tar_map( # Static branching over scenarios
  values = scenarios,
  
  tar_target(
    name = prior,
    command = setup_prior(scenario)
  ),
  
  tar_rep( # Dynamic branching for simulations
    name = ranks,
    command = run_simulation(scenario, prior),
    batches = 1000,
    reps = 1
  )
)
```

:::


## Auto-scaled distributed computing

![](./images/parallel1.png){fig-align="center"}

## Auto-scaled distributed computing

![](./images/parallel2.png){fig-align="center"}

## Auto-scaled distributed computing

![](./images/parallel3.png){fig-align="center"}

## Auto-scaled distributed computing

![](./images/parallel4.png){fig-align="center"}


## Validation results

![](./images/ranks.png){fig-align="center"}

::: {.nonincremental}

SBC ranks are roughly uniform, as expected.

:::

# Recap


## Benefits of pipeline tools

<br>

::::{.columns}

:::{.column width="50%"}

<center>
<img src="./images/targets.png" height = "400px">
</center>

:::

:::{.column width="50%"}

<center>
<div style="font-size: 2em;">
1. Time savings
2. Reproducibility
3. Peace of mind
</div>
</center>

:::

::::


## Links to resources

::: {.nonincremental}

* [`targets`](https://docs.ropensci.org/targets)
* [Clinical trial simulation pipeline](https://github.com/wlandau/targets-example-liver)
* [Bayesian MMRM SBC pipeline](https://github.com/openpharma/brms.mmrm/tree/main/vignettes/sbc)

:::

## Link to slides {.nonincremental}

<https://wlandau.github.io/useR2025>

<center>
<a href="https://wlandau.github.io/useR2025"><img src="./images/qr-slides.png" height="500px"></a>
</center>

## Sources {.tiny}

:::{.nonincremental}

* Brilleman, S. L., M. J. Crowther, M. Moreno-Betancur, J. Buros Novik, and R. Wolfe. 2018. "Joint Longitudinal and Time-to-Event Models via Stan." In StanCon 2018. https://github.com/stan-dev/stancon_talks/.
* Dickson, E. R., T. R. Fleming, R. H. Wiesner, W. P. Baldus, C. R. Fleming, J. Ludwig, and J. T. McCall. 1985. "Trial of Penicillamine in Advanced Primary Biliary Cirrhosis." New England Journal of Medicine 312 (16): 1011–15. https://doi.org/10.1056/NEJM198504183121602.
* Goodrich, B., J. Gabry, I. Ali, and S. L. Brilleman. 2024. "rstanarm: Bayesian applied regression modeling via Stan." https://mc-stan.org/rstanarm.
* Landau, W. M., Kunzmann, K., Sidi, Y., Stock, C. 2024. "brms.mmrm: Bayesian MMRMs using 'brms'". R package version 1.1.1, <https://openpharma.github.io/brms.mmrm/>.
* Landau, W. M. 2021. "The targets R package: a dynamic Make-like function-oriented pipeline toolkit for reproducibility and high-performance computing." Journal of Open Source Software 6 (57): 2959. https://doi.org/10.21105/joss.02959.
* Lawrence, G. A., M. E. Boye, M. J. Crowther, J. G. Ibrahim, G. Quartey, S. Micallef, and F. Y. Bois. 2016. "Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group." Statistics in Medicine 34 (14): 2181–95. https://doi.org/10.1002/sim.6141.
* Modrák, M., Moon, A. H., Kim, S., Bürkner, P., Huurre, N., Faltejsková, K., Gelman, A., Vehtari, A. 2023. "Simulation-Based Calibration Checking for Bayesian Computation: The Choice of Test Quantities Shapes Sensitivity". Bayesian Analysis. <https://doi.org/10.1214/23-BA1404>.
* Therneau, T. M., and P. M. Grambsch. 2000. Modeling Survival Data: Extending the Cox Model. New York: Springer.
:::


## Image credit {.tiny}

:::{.nonincremental}

* <https://unsplash.com/photos/brown-and-gray-stones-on-white-surface-hUjSO5dZA_E>
* <https://unsplash.com/photos/person-stepping-on-blue-stairs-7_kRuX1hSXM>
* <https://unsplash.com/photos/red-white-and-black-round-wheel-RjqCk9MqhNg>
* <https://unsplash.com/photos/matrix-movie-still-iar-afB0QQw>
* <https://unsplash.com/photos/black-and-gray-stethoscope-yo01Z-9HQAw>
* <https://unsplash.com/photos/white-printing-paper-with-numbers-Wpnoqo2plFA>
* <https://unsplash.com/photos/woman-in-brown-sweater-covering-her-face-with-her-hand-_sh9vkVbVgo>
* <https://unsplash.com/license>
* `images/hmc.png`: Prof. David Kahle, Baylor University.

:::
